The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Johnson & Johnson

  • JNJ
  • NYSE
  • Consumer Products
  • Latest 98.96
  • Currency US$
  • Change 0.21
  • Percent Change 0.213 %
  • Volume 9,153,584
  • Thu Apr 17, 2014 04:00 PM EDT NYSE data delayed 15 minutes.
  • Open 98.69
  • Previous Close 98.96
  • High 99.65
  • Low 98.69
  • Bidx0 98.35
  • Askx0 99.85
  • 52-week High04/16 99.71
  • 52-week Low06/20 82.07
  • Beta 0.578
  • Market Cap 279,209.71M
  • EPS 5.52
  • P/E 17.928
  • Forward P/E 15.63
  • PEG 2.67
  • Annual Dividend 2.64
  • Yield 2.668

News

Financials & Calendars

Income Statement

  • Sales $71,312,000,000
  • Earnings $13,831,000,000
  • Return on Equity 39.59%

Cash Flow

  • Cash Flow --
  • Cash $20,927,000,000
  • Current Ratio 2.20

12 months ended Dec 31, 2013.

Trailing 12 month results shown above.
All data is in U.S. dollars.

Balance Sheet

  • Assets $132,680,000
  • Liabilities $58,630,000
  • Liabilities-to-Equity Ratio 0.79

Price Ratios

  • Price to Sales 3.92
  • Price to Book 3,806.15
  • Price to Cash Flow n/a

Event Calendar

Event Last   Next  
Earnings Apr 15 $1.48 Jul 15 $1.52
Surprises Apr 15 4.05% n/a n/a
Dividends Feb 21 $0.66 n/a n/a
Splits n/a -- n/a n/a

12 months ended Apr 19, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.

Related Securities
Symbol Type Latest % Chg

Officers

  • A. Gorsky Chairman&Chief Executive Offic
  • D. J. Caruso Chief Financial Officer
  • Company Type: n/a
  • Company Status: n/a
  • Full-time Employees: n/a
  • Incorporation: United States,
    n/a
  • Top 1000 Ranking: Profit: n/a
    Revenue: n/a
    Assets: n/a

Head Office

ONE JOHNSON & JOHNSON PLZ
NEW BRUNSWICK, NJ
08933

Phone: (732)-524-2455
Fax: (732)-2140332


www.jnj.com

Ideas & Discussion

Live Discussion of JNJ on StockTwits